Back
Immuneering Stock Price Chart
Sponsored
IMRX
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
IMRX
Immuneering
Last Price:
$2.28
Seasonality Move:
-14.17%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Immuneering Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.88 | Buy |
20-day SMA: | 2.03 | Buy |
50-day SMA: | 2.01 | Buy |
200-day SMA: | 1.8 | Buy |
8-day EMA: | 2.01 | Buy |
20-day EMA: | 2 | Buy |
50-day EMA: | 2 | Buy |
200-day EMA: | 2.58 | Sell |
Immuneering Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 59.03 | Buy |
Chaikin Money Flow: | 203121 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.85 - 2.21) | Buy |
Bollinger Bands (100): | (1.35 - 2.41) | Buy |
Immuneering Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Immuneering Stock
Is Immuneering Stock a Buy?
-
Immuneering share price is 2.25 while IMRX 8-day simple moving average is 1.88, which is a Buy signal.
-
The stock price of IMRX is 2.25 while Immuneering 20-day SMA is 2.03, which makes it a Buy.
-
Immuneering 50-day simple moving average is 2.01 while IMRX share price is 2.25, making it a Buy technically.
-
IMRX stock price is 2.25 and Immuneering 200-day simple moving average is 1.80, creating a Buy signal.
IMRX Technical Analysis vs Fundamental Analysis
Buy
53
Immuneering (IMRX)
is a Buy
Is Immuneering a Buy or a Sell?
-
Immuneering stock is rated a BuyThe current Immuneering [IMRX] share price is $2.25. The Score for IMRX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Immuneering Stock Info
Market Cap:
69.9M
Price in USD:
2.25
Share Volume:
338.5K
Immuneering 52-Week Range
52-Week High:
7.92
52-Week Low:
1.00
Buy
53
Immuneering (IMRX)
is a Buy
Immuneering Share Price Forecast
-
What is the Immuneering stock price today?The Immuneering stock price is 2.25 USD today.
-
Will IMRX stock go up or go down?Immuneering> share price is forecast to RISE/FALL based on technical indicators
-
Is Immuneering overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Immuneering is not overvalued.
Is Immuneering Stock a Buy?
-
Immuneering share price is 2.25 while IMRX 8-day exponential moving average is 2.01, which is a Buy signal.
-
The stock price of IMRX is 2.25 while Immuneering 20-day EMA is 2.00, which makes it a Buy.
-
Immuneering 50-day exponential moving average is 2.00 while IMRX share price is 2.25, making it a Buy technically.
-
IMRX stock price is 2.25 and Immuneering 200-day simple moving average is 2.58, creating a Sell signal.
Fundamental Analysis of Immuneering
Is Immuneering a good investment?
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.17 per share.
Technical Analysis of Immuneering
Should I short Immuneering stock?
-
IMRX Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Immuneering is a Sell
-
Immuneering Relative Strength Index (RSI) is 59.03, which suggest Immuneering is overbought
-
The Bollinger Bands (25) for Immuneering is (1.85 - 2.21), which suggest Immuneering is a Buy
-
The Bollinger Bands (100) for Immuneering is (1.35 - 2.41), which suggest Immuneering is a Buy
* Immuneering stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.